Current Releases
Archived Releases
Media Coverage

Return to Press Releases View Archived

April 5 2007

NUCRYST Pharmaceuticals Corp.
Annual General Meeting of Shareholders

Thursday, May 3, 2007
Kellogg Room
Hilton Boston Financial District
89 Broad St.
Boston, MA
10:00 a.m. EDT

NUCRYST Pharmaceuticals Corp. will hold its Annual General Meeting of Shareholders and Investor Briefing on Thursday, May 3, 2007 at 10:00 a.m. EDT. The meeting will be held at the Hilton Boston Financial District, Kellogg Room, 89 Broad Street in Boston. An agenda has been posted on the NUCRYST website,

Both the meeting and investor briefing will be webcast live at An audio file of the webcast will be archived and posted on the NUCRYST website.

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat™ trade mark: Acticoat™ products incorporate NUCRYST’s SILCRYST™ coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form for use as an active pharmaceutical ingredient, referred to as NPI 32101.

A more detailed discussion of NUCRYST’s 2006 year end results can be found in the 2006 Consolidated Financial Statements and Management’s Discussion and Analysis, which are available at and and in NUCRYST’s 2006 Annual Report on Form 10-K, which will be available on the same websites. NUCRYST filings are also available at


For more information, please contact:
Gillian McArdle

Return to Press Releases View Archived

  • Stock Quote
  • Leadership
  • Join Email Club